|
Volumn 160, Issue 5, 2003, Pages 996-998
|
A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DOCOSAHEXAENOIC ACID;
OMEGA 3 FATTY ACID;
PLACEBO;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
FOLLOW UP;
HUMAN;
MAJOR DEPRESSION;
MONTGOMERY ASBERG DEPRESSION RATING SCALE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT OUTCOME;
ADOLESCENT;
ADULT;
COMPARATIVE STUDY;
DEPRESSION;
FEMALE;
MALE;
MIDDLE AGED;
OUTCOME ASSESSMENT;
PSYCHOLOGICAL ASPECT;
PSYCHOLOGICAL RATING SCALE;
ADOLESCENT;
ADULT;
DEPRESSIVE DISORDER;
DOCOSAHEXAENOIC ACIDS;
DOUBLE-BLIND METHOD;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
OUTCOME ASSESSMENT (HEALTH CARE);
PLACEBOS;
PSYCHIATRIC STATUS RATING SCALES;
TREATMENT OUTCOME;
|
EID: 0037844785
PISSN: 0002953X
EISSN: None
Source Type: Journal
DOI: 10.1176/appi.ajp.160.5.996 Document Type: Article |
Times cited : (325)
|
References (8)
|